|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule. |
| 公司地址
| 960 San Antonio Road, Palo Alto, CA, USA, 94303 |
| 電話號碼
| +1 650 516-4310 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.scilexholding.com |
| 員工數量
| 115 |
| Dr. Henry Ji,PhD |
Executive Chairperson of the Board, Chief Executive Officer and President |
美元 1.25M |
21/08/2025 |
| Mr. Hoi Stephen Ma |
Chief Operating Officer, Director, Chief Financial Officer, Senior Vice President, Secretary and Principal Accounting Officer |
美元 600.00K |
07/10/2025 |
|
|
| Dr. Jay Chun, M.D.,PhD |
Independent Director |
16/05/2025 |
| Dr. Yue Alexander Wu, PhD |
Independent Director |
16/05/2025 |
| Mr. Dorman Followwill |
Independent Director |
16/05/2025 |
| Dr. Henry Ji,PhD |
Executive Chairperson of the Board, Chief Executive Officer and President |
21/08/2025 |
| Mr. Hoi Stephen Ma |
Chief Operating Officer, Director, Chief Financial Officer, Senior Vice President, Secretary and Principal Accounting Officer |
07/10/2025 |
|
|
|
|
